Eventide Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $13.7M | Sell |
|
|||||
|
2024
Q4 | $33.2M | Hold |
|
|||||
|
2024
Q3 | $34.1M | Buy |
|
|||||
|
2024
Q2 | $36.1M | Buy |
|
|||||
|
2024
Q1 | $17.5M | Buy |
|
|||||
|
2023
Q4 | $8.6M | Sell |
|
|||||
|
2023
Q3 | $14.9M | Hold |
|
|||||
|
2023
Q2 | $14M | Sell |
|
|||||
|
2023
Q1 | $25.8M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $52M | Sell |
|
|||||
|
2020
Q4 | $159M | Hold |
|
|||||
|
2020
Q3 | $131M | Sell |
|
|||||
|
2020
Q2 | $160M | Hold |
|
|||||
|
2020
Q1 | $97.4M | Hold |
|
|||||
|
2019
Q4 | $129M | Sell |
|
|||||
|
2019
Q3 | $91.8M | Buy |
|
|||||
|
2019
Q2 | $171M | Buy |
|
|||||
|
2019
Q1 | $101M | Hold |
|
|||||
|
2018
Q4 | $92.2M | Buy |
|
|||||
|
2018
Q3 | $100M | Buy |
|
|||||
|
2018
Q2 | $49.6M | Buy |
|
|||||
|
2018
Q1 | $16.7M | Buy |
|
|||||
|
2017
Q4 | $8.96M | Hold |
|
|||||
|
2017
Q3 | $7.3M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $6.49M | Hold |
|
|||||
|
2015
Q4 | $12.8M | Buy |
|
|||||
|
2015
Q3 | $10.5M | Buy |
|
|||||
|
2015
Q2 | $7.88M | Hold |
|
|||||
|
2015
Q1 | $3.44M | Hold |
|
|||||
|
2014
Q4 | $3.75M | Hold |
|
|||||
|
2014
Q3 | $5.47M | Hold |
|
|||||
|
2014
Q2 | $7.72M | Hold |
|
|||||
|
2014
Q1 | $6.23M | Buy |
|
|||||
|
2013
Q4 | $2.89M | Buy |
|